You are here: Welcome » Peter McCullough

Peter McCullough

Dr. Peter McCullough is board certified in internal medicine, cardiovascular diseases, and clinical lipidology. He cares for advanced patients with common medical problems including heart disease, kidney disease, lipid disorders, and diabetes. He has become an expert on COVID-19 illness and welcomes recovered patients into his practice. On October 29, 2022, it was reported that McCullough was stripped of his medical license by a Texas medical board.1)



On February 22, 2023, McCullough published an article highlighting the results of a prospective double-blind, placebo-controlled trial of a xylitol based nasal spray in the prevention of SARS-CoV-2 infection in exposed healthcare workers in two hospitals in Uttar Pradesh, India.2)



Graduate: Certificate of Graduate Liberal Arts Studies: Southern Methodist University (2016)

Fellowship, Cardiovascular Disease: William Beaumont Hospital (presently Oakland University William Beaumont School of Medicine), Royal Oak, MI (1997)

Chief Cardiovascular Fellow: William Beaumont Hospital (presently Oakland University William Beaumont School of Medicine), Royal Oak, MI (1996-1997)

Graduate: Master of Public Health/General Epidemiology, University of Michigan School of Public Health (1994)

Internship/Residency, Internal Medicine: University of Washington School of Medicine, Seattle, WA (1991)

Medical School, MD Degree: University of Texas Southwestern Medical School, Dallas, TX (1988)

Undergraduate (honors): Bachelor of Science: Biology and Psychology, Baylor University, Waco, TX (1984)

Professional Experience

Chief Academic and Scientific Officer (Academic Dean Equivalent) - St. John Providence Health System, (2010-2013)

Division Chief, Nutrition and Preventive Medicine, Medical Director, Preventive Cardiology - Oakland University William Beaumont School of Medicine (2002-2010)

Associate Professor of Medicine/Cardiology Section Chief - University of Missouri-Kansas City School of Medicine (2000-2002)

Assistant Professor of Medicine, Program Director in Cardiology, Henry Ford Hospital (1997-2000)

Professional Affiliations

Alpha Omega Alpha, National Honor Medical Society (1988-present)

American Heart Association, Council on Epidemiology and Prevention (1995-present)

American College of Cardiology (1997 to present)

Association of American Physicians and Surgeons (2020 to present)

Cardiorenal Society of America -

Founding Executive Board Member (2013-present)

Vice President (2014-2016)

President (2016-present)


Dr. McCullough has broadly published on a range of topics in medicine with > 1000 publications and > 600 citations in the National Library of Medicine. His works include the “Interface between Renal Disease and Cardiovascular Illness” in Braunwald’s Heart Disease Textbook. Dr. McCullough is a founder and current president of the Cardiorenal Society of America, an organization dedicated to bringing cardiologists and nephrologists together to work on the emerging problem of cardiorenal syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, British Medical Journal and other top-tier journals worldwide. He is the editor-in-chief of Reviews in Cardiovascular Medicine and senior associate editor of the American Journal of Cardiology. He serves on the editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), and the European Medicines Agency. He has served as member or chair of data safety monitoring boards of 24 randomized clinical trials.

Leadership During the SARS-CoV-2/COVID-19 Pandemic

Since the outset of the SARS-CoV-2 pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 35 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs concerning early ambulatory treatment of high-risk patients with COVID-19. Dr. McCullough is a COVID-19 survivor himself and welcomes post-COVID-19 patients into his practice and will help them through the range of post-infection complications.

To inquire on Covid-19 related questions email


Public Talks

Policy Talks

Back to top